In this context, we hypothesized that M2-TAMs and via STAT3/NF-κB crosstalk can modulate important hallmarks of tumor progression, negatively affecting the survival of 691 patients with cervical cancer. The gene discussed is NFKB1; the disease is cervical carcinoma.